Schering - PDFSEARCH.IO - Document Search Engine

Schering
Results: 483

#	Item
131	MedDRA Blue Ribbon Panel on Extent of Versioning and Feasibility of Annual Release 13 May 2009 Schering-Plough Corporation, Kenilworth, NJ, USA MedDRA® is a registered trademark of the International Federation Add to Reading List Source URL: www.meddra.org Language: English - Date: 2013-03-29 10:03:40 Grumman Transportation in the United States Science Transport Pharmacology MedDRA Northrop Grumman
132	Microsoft Word - Final VCU Sept[removed]for posting.doc Add to Reading List Source URL: www.pmprb-cepmb.gc.ca Language: English - Date: 2013-01-18 14:33:28 Merck Androgens Neuroendocrinology Testosterone Schering-Plough Virginia Commonwealth University Hypogonadism Schering Endocrine system Andrology Endocrinology
133	Microsoft Word - Claritin Allergy and Sinus ES - VCU - Oct[removed]posted Feb[removed]doc Add to Reading List Source URL: www.pmprb-cepmb.gc.ca Language: English - Date: 2013-01-18 14:33:32 Schering-Plough Merck Organic chemistry Loratadine Wyeth Schering Pseudoephedrine Sinus Decongestants Chemistry Organochlorides
134	XENICAL® (ORLISTAT) FOR HYPERCHOLESTEROLEMIA MEDICATIONS CRITERIA Pharmacology: Orlistat: Reverse lipase inhibitor that acts by inhibiting the absorption of dietary fats. Medication: Add to Reading List Source URL: www.nhhealthyfamilies.com Language: English - Date: 2014-09-11 16:49:00 Lactones Merck Schering-Plough Bile acid sequestrants Hepatology Orlistat HMG-CoA reductase Cholesterol Pharmaceutical drug Chemistry Organic chemistry Medicine
135	ABT-799 M03-661 Abbreviated Clinical Study Report R&D[removed] Add to Reading List Source URL: www.abbvie.com Language: English - Date: 2014-12-04 15:09:34 Organofluorides Merck Prodrugs Schering-Plough Fenofibrate Ezetimibe Statin Clinical trial Low-density lipoprotein Chemistry Organic chemistry Ketones
136	Actions Taken by FDA Center for Veterinary Medicine The following corrections or additions to the list were completed in November[removed]Original Approvals This section displays the original approval. To read the complete Add to Reading List Source URL: www.fda.gov Language: English Amides Cancer research Otologicals Tetracycline Anaplasma Veal Anaplasmosis Pasteurella Schering-Plough Medicine Proteobacteria Biology
137	Kenneth C. Frazier Chairman of the Board and Chief Executive Officer Merck & Co., Inc. Kenneth C. Frazier is chairman of the board and chief executive officer of Merck & Co., Inc. Previously, Ken served as president of M Add to Reading List Source URL: www.merck.com Language: English - Date: 2013-11-25 10:21:38 Dow Jones Industrial Average Merck & Co. Readington New Jersey Pharmaceutical Research and Manufacturers of America Kenneth Frazier Merck KGaA Merck Pharmaceutical industry Schering-Plough
138	Date of Approval: October 14, 2014 FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA[removed] Add to Reading List Source URL: www.fda.gov Language: English Flunixin Norbrook Organofluorides Bioequivalence Non-steroidal anti-inflammatory drug Meglumine Schering-Plough Pharmacology Pharmacokinetics Pharmaceutical sciences
139	Microsoft Word - aD0E.tmpa.doc Add to Reading List Source URL: www.abbvie.com Language: English - Date: 2014-10-07 00:32:17 Cardiology Organofluorides Lipoproteins Merck Schering-Plough Ezetimibe Statin Fenofibrate Low-density lipoprotein Chemistry Medicine Organic chemistry
140	PDF Document Add to Reading List Source URL: media.chop.edu Language: English - Date: 2014-08-19 15:01:31 Chronic lower respiratory diseases Glucocorticoids Mometasone furoate Organochlorides Schering-Plough Asthma Candidiasis Cough Pulmonology Medicine Respiratory therapy

UPDATE